John McElwee, PhD, is a Senior Advisor in Molecular Pathology and Clinical Diagnostics at Eli Lilly, where they focus on oncology drug development. With over 25 years in the life sciences, McElwee has previously served as a Postdoctoral Associate at Cornell University, specializing in epigenetics and contributing to significant interdisciplinary research. McElwee earned a PhD in Biomedical Sciences from Cornell University and holds a BS in Biological Sciences from Binghamton University. Their experience also includes roles in research and development at Regeneron Pharmaceuticals, where they implemented a sperm cryopreservation program and developed transgenic models.
This person is not in any teams
This person is not in any offices